Methods and compositions for detecting genetic material

US12097495B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12097495-B2
Application numberUS-202217750195-A
CountryUS
Kind codeB2
Filing dateMay 20, 2022
Priority dateFeb 18, 2011
Publication dateSep 24, 2024
Grant dateSep 24, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides methods and compositions for detecting polynucleotides in a sample and for quantifying polynucleotide load in a sample. The polynucleotides can be associated with a disease, disorder, or condition. In some applications, methylated DNA is quantified, e.g., in order to determine the load of polynucleotides in a sample. The present disclosure also provides methods and compositions for determining the load of fetal polynucleotides in a biological sample, e.g., the load of fetal polynucleotides (e.g., DNA, RNA) in maternal plasma. The present disclosure provides methods and compositions for detecting cellular processes such as cellular viability, growth rates, and infection rates. This disclosure also provides compositions and methods for detecting differences in copy number of a target polynucleotide. In some embodiments, the methods and compositions provided herein are useful for diagnosis of fetal genetic abnormalities, when the starting sample is maternal tissue (e.g., blood, plasma). The methods and materials described apply techniques for allowing detection of small, but statistically significant, differences in polynucleotide copy number.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of detecting methylated DNA, comprising: a) contacting a DNA sample comprising a major population and a minor population with a methylation-sensitive reagent; b) partitioning said DNA sample into a plurality of spatially-isolated partitions; detecting a first locus within said DNA sample, wherein said-first locus is c) hypermethylated in the minor population and wherein the first locus is selected from the group consisting of CASP8, RARB, SCGB3A1, DAB2IP, PTPN6, THY1, TMEFF2, and PYCARD; and d) quantifying a first quantity of said first locus, thereby detecting methylated DNA. 2. The method of claim 1 , further comprising detecting a second locus within said DNA sample, wherein said second locus is present in both the major population and the minor population and wherein said second locus is not significantly cleaved by said methylation-sensitive reagent. 3. The method of claim 1 , further comprising detecting a third locus within said DNA sample, wherein said third locus is present in both the major population and the minor population and wherein said third locus is significantly cleaved by said methylation-sensitive reagent. 4. The method of claim 1 , further comprising amplifying a sequence associated with said first locus to produce a detectable signal. 5. The method of claim 4 , wherein said signal is a fluorescence signal. 6. A The method claim 1 , further comprising: e) detecting a second quantity of a second locus within said DNA sample; and f) comparing said first and second quantities, to obtain a value indicative of a percentage of methylated DNA in the sample. 7. The method of claim 6 , wherein said major population comprises maternal DNA and said minor population comprises fetal DNA. 8. The method of claim 6 , wherein said second locus does not comprise a restriction site recognized by said methylation-sensitive reagent. 9. The method of claim 6 , wherein said second locus is methylated in (a) the major population and (b) the minor population. 10. The method of claim 6 , further comprising detecting a signal associated with a third locus within said DNA sample. 11. The method of claim 10 , wherein said value indicative of the percentage of methylated DNA in said sample is adjusted by a value associated with the presence of said third locus within said DNA sample. 12. The method of claim 6 , further comprising calculating the amount of total DNA in said sample. 13. The method of claim 6 , wherein said detecting of said first and second quantities comprises an amplification reaction. 14. The method of claim 7 , further comprising comparing said value indicative of the percentage of methylated DNA in said DNA sample with a value at an earlier gestational timepoint, thereby detecting a pregnancy-associated disorder. 15. The method of claim 6 , wherein said value indicative of the percentage of methylated DNA in the sample is calculated using a detectable signal from at least a third locus within said DNA sample, wherein said third locus comprises a sequence that is not significantly cleaved by said methylation-sensitive reagent. 16. The method of claim 1 , wherein said spatially-isolated partitions are wells. 17. The method of claim 6 , wherein said spatially-isolated partitions are wells. 18. The method of claim 1 , wherein said methylation-sensitive reagent is a methylation-sensitive enzyme.

Assignees

Inventors

Classifications

  • the components to be mixed being combined in a single independent droplet, e.g. these droplets being divided by a non-miscible fluid or consisting of independent droplets · CPC title

  • Mixing by intersecting jets · CPC title

  • Mixing drops, droplets or bodies of liquid which flow together or contact each other (micromixers using where the materials to be mixed are in the form of droplets B01F33/302) · CPC title

  • using a sheathing stream of a fluid surrounding a central stream of a different fluid, e.g. for reducing the cross-section of the central stream or to produce droplets from the central stream · CPC title

  • mixing simultaneously in two or more mixing receptacles · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12097495B2 cover?
The present disclosure provides methods and compositions for detecting polynucleotides in a sample and for quantifying polynucleotide load in a sample. The polynucleotides can be associated with a disease, disorder, or condition. In some applications, methylated DNA is quantified, e.g., in order to determine the load of polynucleotides in a sample. The present disclosure also provides methods a…
Who is the assignee on this patent?
Bio Rad Laboratories Inc
What technology area does this patent fall under?
Primary CPC classification B01L3/50273. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).